Following judicial approval, Purdue Pharma faces mandatory dissolution after being ordered to pay $225 million in criminal penalties. This landmark decision represents a significant accountability measure against the pharmaceutical company responsible for aggressive OxyContin marketing practices that fueled the opioid epidemic. The settlement addresses how the company misrepresented addiction risks and promoted excessive usage of its painkiller, marking a crucial step in holding major pharmaceutical corporations responsible for their role in the public health crisis.

Summary auto-generated by AI from the original publisher's content. Editorial standards.